Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker.
HanAll Biopharma Co., Ltd. and Daewoong Pharmaceutical Company Ltd. announced the expansion of their open collaboration strategy on 12 June by investing in Vincere Biosciences, a Cambridge, MA-based company developing therapeutics targeting mitophagy
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?